Clinical Trial Update: Euphrasia Eye Drops in Preterm Infants With First Signs of Congestion of Nasolacrimal Duct [Phase 3]

View source ↗

Summary

Phase 3 clinical trial investigating Euphrasia eye drops for congestion of the nasolacrimal duct in preterm infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Nasolacrimal Duct Obstruction
• Preterm Neonates

Drugs mentioned

• Euphrasia eye drops

Snippet

Sponsor: University of Bern | Conditions: Congenita Nasolacrimal Duct Obstruction, Preterm Neonates | Phase 3 | Status: COMPLETED